Stocks · News reference

Chemomab Therapeutics, Scipher Medicine Strike All-Stock Merger Agreement; Combined Entity Expected To Operate Under Scipher Medicine Name, SCIP Ticker On Nasdaq

Jul 8, 2026, 11:37 AMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 19, 2026, 1:25 PMBenzinga Newsdesk
CORRECTION: Chemomab Therapeutics Q2 EPADS $(0.27) Misses $(0.15) Estimate
Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.15) by 80 percent. This is a 25 percent increase over losses of $(0.36) per share
Read original at benzinga
CMMB
BenzingaAug 19, 2026, 12:54 PMBenzinga Newsdesk
Chemomab Therapeutics Q2 EPS $(0.24) Misses $(0.15) Estimate
Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.15) by 60 percent. This is a 33.33 percent increase over losses of $(0.36) per share
Read original at benzinga
CMMB